The table below shows Arcutis Biotherapeutics, Inc.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Revenue
$376.07M
$196.54M
$59.61M
$3.69M
-
-
Cost of revenue
$36.70M
$19.13M
$4.99M
$754.00K
$0.00
-
Gross profit
-
-
-
-
-
-
R&D
$77.05M
$76.42M
$110.58M
$182.44M
$145.56M
$115.31M
SG&A
ARQT annual revenue (10-K history)
Arcutis Biotherapeutics, Inc. reported annual revenue of $376.07M for fiscal year 2025. That is up 91.3% from $196.54M in fiscal 2024. Figures come from the company's audited annual reports as filed with the SEC.